ANA MARÍA GRANDE TEJADA

• Facultad De Medicina Y Ciencias De La Salud
  • GRADO EN MEDICINA
    • pediatría

Tesis:

• 2016-02-08: DESCRIPCIÓN DE ENFERMEDAD MENINGOCÓCICA EN NIÑOS DE 0 A 14 AÑOS EN LA UNIDAD DE CUIDADOS INTENSIVOS PEDIÁTRICOS DE BADAJOZ (1997-2013). EVALUACIÓN DE LA EFICACIA Y SEGURIDAD DE LAS VACUNAS FRENTE A LA ENFERMEDAD OCASIONADA POR MENINGOCOCO B. REVISIÓN SISTEMÁTICA DE LA VACUNA DE MENINGOCOCO B.

Publicaciones:

• 2024: Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus
• 2024: Impact of current influenza vaccination recommendations in risk groups
• 2023: Pleural effusion in a child with a correctly placed ventricle-peritoneal shunt
• 2023: Vaccination schedule for adolescents. Consensus of the AEV, CAV-AEP and SEMA
• 2022: Epidemiology, prevention and control of pertussis in Spain: New vaccination strategies for lifelong protection
• 2020: Recovering lost vaccine coverage due to COVID-19 pandemic
• 2015: Erratum: Estimate of the impact of influenza vaccination with adjuvant MR59 in population over 64 years for the National Health System: Effects and costs (Vacunas (2015) 16, 1:6-11))
• 2015: Estimate of the impact of influenza vaccination with adjuvant MR59 in population over 64 years for the National Health System: Effects and costs
• 2015: Management and monitoring of patients with Duchenne disease
• 2013: Assessment of the MF59-adjuvanted pandemic influenza A/H1N1 vaccine. Systematic review of literature

Más publicaciones